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CO-PRODUCTION OF KNOWLEDGE
Co-producing the covid-19 response in Germany, 
Hong Kong, Lebanon, and Pakistan
Robert Marten and colleagues highlight the benefits of co-production during covid-19 and call 
for it to be become embedded in policy making 
Using scientific evidence for policy making is a challenge at the best of times, but it is particularly difficult during a global pandemic. Policy mak-
ers traditionally receive inputs from health 
professionals and use existing evidence 
to develop health policies and prioritise 
the most effective interventions. However, 
in responding to the covid-19 pandemic, 
policy makers are often grappling with 
complicated decisions based on evidence 
that is still emerging. Even in a crisis, one 
way to strengthen policy making is to col-
laborate with researchers and other stake-
holders, including the public, from the 
start, generating knowledge and research 
to inform policy through a process called 
co-production.
Drawing on our experiences with 
engaging in and observing different 
national responses to the covid-19 
pandemic, we use examples from Germany, 
Hong Kong, Lebanon, and Pakistan to 
illustrate how researchers and national 
policy makers are applying a co-production 
approach. Although these examples 
are unique, diverse, and happening 
within the context of the ongoing covid-
19 pandemic, the findings are relevant 
beyond the crisis. They highlight the 
importance of co-production for policy 
making and how better to generate and 
use local knowledge to improve policy 
and management decisions. The covid-19 
crisis provides an opportunity to accelerate 
the broader adoption of a co-production 
approach by focusing on three cross 
cutting issues: building on established 
structures; working together to co-produce 
research; and disseminating research and 
engaging communities. As defined in this 
series, co-production is when researchers 
work together with knowledge users 
(comprising patients and caregivers, the 
public, clinicians, policy makers, health 
system leaders, and others) to identify a 
problem and produce knowledge, sharing 
power and responsibility from the start to 
the end of the research.
Building on established structures and 
ensuring inclusive representation
The speed and breadth of the covid-19 
pandemic have underscored the need for 
a rapid co-produced response to create 
knowledge that can improve interventions. 
This has resulted in policy makers often 
collaborating with known researchers and 
groups who have the capacity to join such 
a response. For example, while there is no 
“one way” in which researchers and policy 
makers interact, there are often established 
channels, relationships, and structures of 
collaboration. In Germany, existing struc-
tures have been included in the response to 
the covid-19 pandemic, including scientific 
advisory boards, professional associations 
(the Fachgesellschaften), and formal and 
informal working groups and committees 
based in universities and research institutes 
such as the Max Planck Institutes and the 
national public health institute (the Robert 
Koch-Institute).
Similarly, since January 2020, policy 
makers and researchers in Hong Kong have 
closely collaborated to tackle and respond 
to the covid-19 crisis. At the political level, 
Hong Kong’s chief executive convened and 
continues to chair an expert advisory panel 
under a covid focused steering committee 
cum command centre. At the operational 
level, the Department of Health adapted its 
pre-existing scientific advisory committee 
to specifically advise on covid-19. These 
structures are supplemented by frequent 
outreach by the political and policy 
establishment to Hong Kong’s research 
community with the relevant expertise to 
inform policies and covid-19 interventions.
The emerging scientific knowledge on 
covid-19 has generated much interest in 
the media and from the public, and this 
attention has made collaboration more 
complex and challenging than usual. It has 
forced policy makers to rethink the formal 
and informal structures of how, where, 
when, and with whom they collaborate, 
including with researchers as well as the 
broader public, patients, and communities. 
Beyond existing structures, new structures 
w i t h  i m p ro ve d  m u lt i s t a ke h o l d e r 
representation can also create the 
groundwork to change how knowledge is 
co-produced. For example, in Pakistan at 
the start of the pandemic the government 
adopted a “whole of government” 
approach with the establishment of a 
national coordination council chaired by 
the prime minister with health, finance, 
planning, defence, and other ministries. A 
key function of the council was to engage 
researchers in the national response, 
including by supporting the generation 
and use of local evidence and knowledge 
for strategic decision making.
In April 2020 Germany’s National 
Academy of Sciences convened an expert 
group, which included philosophers, 
historians of science, theologians, and 
jurists to advise the government on how to 
emerge ethically from the initial shutdowns 
and loosen its restriction policies.1 
However, this inclusive approach seems 
to be an anomaly. A study of 24 countries’ 
KEY MESSAGES
•   The covid-19 response is creating the 
opportunity for an accelerated and 
inclusive shift towards co-production 
for policy making
•   It has brought a focus to three cross 
cutting issues: building on established 
structures; working together to co-
produce research; and disseminating 
research and engaging communities
•   The covid-19 pandemic has forced 
policy makers to rethink the for-
mal and informal structures of how, 
where, when, and with whom they 
collaborate, including with researchers 
as well as the broader public, patients, 
and communities
•   Unprecedented levels of public atten-
tion during the covid-19  pandemic 
h ave  p o s e d  n ew  ch a l le n ge s  to 
 evidence based policy making, par-
ticularly in terms of communicating 
sometimes complicated science and 
dealing with an overabundance of 
information












J: first published as 10.1136/bm






2 doi: 10.1136/bmj.n243 | BMJ 2021;372:n243 | the bmj
covid-19 task forces found they mostly 
comprised politicians, virologists, and 
epidemiologists, and did not include other 
relevant health and social experts. There 
was also a notable exclusion of women.2
Although governments have primarily 
built on existing structures as a starting 
point for the response, this approach 
may have excluded some groups and 
exacerbated the marginalisation of 
stakeholders who do not have the 
relationships or resources to engage. 
Because of the political context as well 
as power imbalances between and across 
research institutions, many policy makers 
and research entities may not be able to 
pivot and shift long standing structures and 
practices at short notice. The availability 
of human and financial resources within 
research institutions means some are in 
a better position to respond to the rapidly 
evolving demands for evidence by policy 
makers, health and social workers, and 
the broader public. Policy makers may also 
depend on existing structures to collaborate 
with researchers to the detriment of more 
inclusive structures, such as patients, civil 
society groups, and communities.3
Working together to co-produce research to 
improve health outcomes
The scale of the covid-19 pandemic means 
no single entity can provide the needed 
support or engage with all the relevant data 
and possible constituencies. Researchers 
and policy makers are working together to 
pool resources, produce knowledge, and 
develop policy responses. For example, 
Hong Kong’s expert advisory panel, in col-
laboration with local clinicians and scien-
tists, are jointly providing information on 
covid-19 directly to the public. Academics 
at the University of Hong Kong have been 
estimating and publishing real time results, 
known as “nowcasting,” to help inform 
how policy makers determine interventions 
based on risks and how communities and 
individuals adapt their behaviour, such as 
social distancing or working from home, in 
response.4 5 In Pakistan, researchers from 
the Medical Research Council, the National 
Institute of Health, and other academic and 
policy institutions collaborated on a new 
platform to collect and analyse local data 
to inform and shape the government’s 
response.
In Lebanon, researchers at the American 
University of Beirut engaged with the 
Ministry of Public Health in March 2020 to 
identify and prioritise needs around covid-
19 preparedness and response. In close 
collaboration with policy makers, health 
workers, municipalities, non-governmental 
organisat ions,  and communit ies, 
researchers produced Lebanon’s first 
national policy document on the pandemic 
response, reinforcing the need for stricter 
social distancing measures and to guide 
hospital and primary healthcare centre 
preparedness. The pandemic has also 
presented opportunities for researchers, 
communities, and public health advocates 
to shape the policy agenda by bringing 
pressing but often overlooked issues to 
the attention of policy makers. As part 
of efforts to advocate the banning of 
waterpipe smoking, representatives of 
the Tobacco Control Coalition in Lebanon 
underscored the association between 
covid-19 and waterpipe smoking in a 
targeted press conference with the head of 
the parliamentary health committee. In July 
2020 the serving of waterpipes was banned 
in public places.
Researchers, public health specialists, 
epidemiologists, patients, community 
members, policy makers, data analysts, 
and evaluation experts are all generating 
relevant evidence to inform the covid-19 
response. This has produced a massive 
amount of information. For example, by 
September 2020, the New England Journal 
of Medicine had already received more 
than double the number of submissions 
it received in 2019.6 However, much 
of this research has been produced in 
a fragmented way by researchers from 
a single discipline, and it undermines 
the efficiency of a collective response. 
In addition, much of the existing 
research has focused on the treatment 
and management of covid-19, while 
behavioural, environmental, social, and 
systems research and interventions have 
been largely overlooked in the covid-19 
response.7
Disseminating research and engaging 
communities in the covid-19 response
Policy makers have needed rapid responses 
from the scientific community to inform the 
development of policies and approaches to 
the pandemic. The pandemic has also cre-
ated new opportunities for policy makers 
and researchers to share information with 
a wider audience. For example, multiple 
platforms such as social media, emails, 
television and radio interviews, podcasts, 
press conferences, and online webinars are 
used to disseminate research findings. In 
Germany, as in many countries, academ-
ics and scientists have gained national 
prominence similar to that of media com-
mentators or television personalities. Their 
straightforward communication style has 
helped to calm an unsettled public and 
build trust and understanding about 
why interventions are needed. Indeed, it 
has been noted that “scientists who were 
barely known outside a narrow academic 
circle are now household names, lauded 
and vilified in turn in the press and on 
social media.”8 The Lebanese policy docu-
ment on the pandemic response mentioned 
above was launched in a prime time tel-
evision interview as well as being shared 
with parliamentarians, policy makers, and 
representatives of the covid-19 national 
committee. Moreover, public awareness 
of research is increasing and reflects the 
growing popular interest to engage with, 
and contest, science in the ongoing covid-
19 response.
In Pakistan, researchers coordinated 
broad communication and outreach 
initiatives with communities and the 
health workforce through print, electronic, 
and social media. Policy makers and 
researchers engaged religious leaders and 
celebrities as well as government leaders 
and athletes to share important health 
information with the broader public. Public 
audiences are also playing an active part 
in shaping research and the covid-19 
response. For example, there is growing 
evidence of participatory action research 
transforming communities’ covid-19 
responses across regions.9 There is also 
an increasing sense of a “new normal,” 
in which patient voices are integral 
partners in co-producing the response10 
and in which new approaches capitalise 
on online and digital communication to 
ensure patient engagement.11 As a covid-19 
vaccine is rolled out, continued community 
engagement will be crucial and will likely 
be feasible only with strong community 
participation.12
Given the nature of the pandemic, 
knowledge, recommendations and advice 
are constantly evolving, leading to shifts 
in positions and adaptations in strategy. 
Such changes can be destabilising and 
undermine trust in government authorities, 
even more so in situations of social 
unrest.13 Political and social pressures 
to communicate information may also 
run counter to the established culture of 
research and science, including in the 
way research is disseminated. The covid-
19 pandemic has reinforced longstanding 
tensions within the research community 
about how best to engage with political 
stakeholders and share research findings 
with the public, while also maintaining 
scientific integrity and independence.
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T h e  p a n d e m i c  h igh l igh t s  h o w 
co-production can help fill the “know-do” 
gap by accelerating implementation of 
interventions to tackle the pandemic. For 
example, Hong Kong’s nowcasting effort 
showcases how science can directly shape 
and influence both policy interventions and 
how individuals engage with science and 
data to understand interventions. Covid-
19 is transforming how we understand 
those who are “knowledge users” and 
those who are “knowledge producers,” 
and this understanding is widening as the 
pandemic is affecting almost everyone, 
everywhere.
Conclusion
The ongoing covid-19 pandemic shows the 
importance of a co-production approach to 
decision making that engages policy mak-
ers, researchers, communities, and other 
stakeholders throughout the process. To 
support a co-production approach, exist-
ing structures have been built on and 
formal and informal alliances have been 
established in response to the pandemic. 
However, these efforts and relationships 
need to be consolidated and institutional-
ised for policy making. Moving forward, the 
covid-19 experience has revealed the need 
for mechanisms to coordinate and build 
bridges between and across organisations, 
institutions, and networks for more effec-
tive policy responses. It has also reinforced 
the need to strengthen and institutionalise 
co-production efforts to promote a more 
proactive, inclusive, swift, and evidence 
informed response to future public health 
crises.
The current and ongoing covid-19 crisis 
is changing how and when researchers 
and policy makers collaborate to develop, 
create, and apply knowledge for policy 
making and particularly how researchers 
engage with the broader public. The result 
for now, however, is that the covid-19 
response is often being co-produced by 
default instead of by design. We must build 
on the positive signs and opportunities 
created by the covid-19 response to 
accelerate further an inclusive shift towards 
the co-production of evidence based policy 
making.
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